HESTERBIO - Hester Biosciences

Hester Biosciences

HESTERBIO · Pharma > Pharmaceuticals & Drugs · Chairman: Bhupendra V Gandhi · MD: Rajiv Gandhi · Listing date: March 13, 2015 · Employees: 428 · Ahmedabad · http://www.hester.in

Stock Price vs Company Growth

1.2%

1.4%

2.0%

12.0%

10.0%

32.4%

0.6%

10y

11.5%

all

12.8%

🤔 How to analyze this graph?

Last Traded Price

₹ 1,606 1.2%

1,551

1,821

Company Overview

Sales

300 Cr

Growth: 3.3%

Profit after Tax

43.8 Cr

Growth: 16.6%

Small Cap

1,366 Cr

P/E: 30.6x

Industry P/E: 32.9x

Fundamentals

Sales (Cr)	₹ 300
Growth	3.3%
EBITDA	19.6%
P/S	4.6x
Dividend	0.2%
P/E	30.6x
Book Value	₹ 406
PEG Ratio	9.1x
ROE	13.4%
P/B	3.9x

Shareholding Pattern

Institutions

Kuntal Hasmukhlal Shah

3.05 %

Manish Jain

2.56 %

Darshna Dinesh Kapadia

1.81 %

Vinay Shah

1.28 %

Iepf

0.89 %

Promoters

Rajiv D Gandhi

10.47 %

Sanjiv Dinesh Gandhi

8.2 %

Nina R Gandhi

8.19 %

Ravin Gandhi

4.74 %

Bela Gandhi

4.71 %

Others

Increase Decrease No change

Company Profile Detailed

Hester Biosciences was incorporated on April 29, 1987 as a Private Limited Company by the name of Hester Pharmaceuticals Limited. It was subsequently converted into a Public Limited Company on November 1, 1993. The company is engaged in the manufacturing of poultry vaccines. The company has been promoted by Rajiv D. Gandhi his brother Sanjiv D. Gandhi and Dr. Bhupendra V. Gandhi. The company changed its name to the present in 2008.

Belongs to (4 Indices)

Investors (50)

sbi.equi...

anup.cha...

mahaveer...

Followers (11)

nitin2

keerthi

deepak